| Year |
Title |
Altmetric |
| 2022
|
Retraction: CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway (Cancer Research (2022) 82 (3406) DOI: 10.1158/0008-5472.CAN-08-2780).
Cancer Research.
82:3406.
2022
|
|
| 2022
|
Retraction: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression (Cancer Research (2022) 82 (3405) DOI: 10.1158/0008-5472.CAN-09-2863).
Cancer Research.
82:3405.
2022
|
|
| 2022
|
Erratum: Withdrawal: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (Journal of Biological Chemistry (2008) 283(7) (4283–4294), (S0021925820697381), (10.1074/jbc.M707465200)).
Journal of Biological Chemistry.
298.
2022
|
|
| 2021
|
Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer Cells.
Frontiers in Cell and Developmental Biology.
9.
2021
|
|
| 2021
|
Erratum: CXCL12γ promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes (Cancer Research (2018) 78 (2026–2039) DOI: 10.1158/0008-5472.CAN-17-2332).
Cancer Research.
81:5777.
2021
|
|
| 2021
|
Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis.
Journal of Bone Oncology.
30.
2021
|
|
| 2021
|
Dura promotes metastatic potential in prostate cancer through the CXCR2 pathway.
Journal of Neuro-Oncology.
153:33-42.
2021
|
|
| 2021
|
Retraction notice to <“Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis”> <[Cellular Signaling 17/12 (2005) 1578–1592]> (Cellular Signalling (2005) 17(12) (1578–1592), (S0898656805000677), (10.1016/j.cellsig.2005.03.022)).
Cellular Signalling.
80.
2021
|
|
| 2021
|
Retraction: A glycolytic mechanism regulating an angiogenic switch in prostate cancer (Cancer Research (2007) 67 (149-159) DOI: 10.1158/0008-5472.CAN-06-2971).
Cancer Research.
81:1623.
2021
|
|
| 2021
|
Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
Neoplasia.
23:102-111.
2021
|
|
| 2020
|
CXCL12γ induces human prostate and mammary gland development
2020
|
|
| 2020
|
Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6.
Translational Oncology.
13.
2020
|
|
| 2020
|
Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer
2020
|
|
| 2020
|
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion.
Translational Oncology.
13.
2020
|
|
| 2020
|
The assessment of stress, depression, and inflammation as a collective risk factor for periodontal diseases: a systematic review.
Clinical Oral Investigations.
24.
2020
|
|
| 2019
|
Anticancer polymers designed for killing dormant prostate cancer cells.
Scientific Reports.
9.
2019
|
|
| 2019
|
Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells (Scientific Reports, (2019), 9, 1, (1096), 10.1038/s41598-018-36608-5).
Scientific Reports.
9.
2019
|
|
| 2019
|
Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis.
Journal of Experimental Medicine.
216:2883-2899.
2019
|
|
| 2019
|
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer
2019
|
|
| 2019
|
Circulating Tumor Cell–Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer.
Neoplasia.
21:802-809.
2019
|
|
| 2019
|
Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.
Bone.
119:82-86.
2019
|
|
| 2019
|
Determining competitive potential of bone metastatic cancer cells in the murine hematopoietic stem cell niche.
Methods in Molecular Biology.
2002:141-150.
2019
|
|
| 2018
|
Dural cells release factors which promote cancer cell malignancy and induce immunosuppressive markers in bone marrow myeloid cells.
Neurosurgery.
83:1306-1316.
2018
|
|
| 2018
|
Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis.
Journal of Cellular Biochemistry.
119:8074-8083.
2018
|
|
| 2018
|
CXCL12g promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes.
Cancer Research.
78:2026-2039.
2018
|
|
| 2018
|
Multigene profiling of CTCs in mCRPC identifies a clinically relevant prognostic signature.
Molecular Cancer Research.
16:643-654.
2018
|
|
| 2018
|
Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.
Journal of Cellular Biochemistry.
119:3697-3705.
2018
|
|
| 2018
|
Periodontal Treatment in Cancer Patients: an Interdisciplinary Approach.
Current Oral Health Reports.
5:7-12.
2018
|
|
| 2017
|
Sympathetic signaling reactivates quiescent disseminated prostate cancer cells in the bone marrow.
Molecular Cancer Research.
15:1644-1655.
2017
|
|
| 2017
|
A comparative analysis of the Su-pung-er and Bayne testimonies related to the Franklin expedition.
Polar Record.
53:561-579.
2017
|
|
| 2017
|
Biochemical Changes in the Niche Following Tumor Cell Invasion.
Journal of Cellular Biochemistry.
118:1956-1964.
2017
|
|
| 2017
|
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
Journal of Cellular Biochemistry.
118:891-902.
2017
|
|
| 2017
|
A critical assessment of the oral condition of the crew of the franklin expedition.
Arctic.
70:25-36.
2017
|
|
| 2017
|
Clinical assessment of urinary tract damage during sustained-release estrogen supplementation in mice
2017
|
|
| 2017
|
Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer [Oncotarget., 7, (2016) (41217-41232)] doi: 10.18632/oncotarget.9251.
Oncotarget.
8:38075.
2017
|
|
| 2017
|
Dental students', alumni, and dentists' perspectives on leadership: Impact of the scholars program in dental leadership.
Journal of Dental Education.
81:44-53.
2017
|
|
| 2016
|
Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow.
Journal of Cellular Biochemistry.
2815-2824.
2016
|
|
| 2016
|
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
Scientific Reports.
6.
2016
|
|
| 2016
|
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Neoplasia.
18:553-566.
2016
|
|
| 2016
|
The role of hematopoietic stem cell niche in prostate cancer bone metastasis.
Journal of Bone Oncology.
5:117-120.
2016
|
|
| 2016
|
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Oncotarget.
7:41217-41232.
2016
|
|
| 2016
|
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Oncotarget.
7:25698-25711.
2016
|
|
| 2016
|
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer.
Neoplasia.
18:1-9.
2016
|
|
| 2015
|
Bone: Elucidating which cell erythropoietin targets in bone.
Nature Reviews Endocrinology.
11:263-264.
2015
|
|
| 2015
|
Tissue engineering a surrogate niche for metastatic cancer cells.
Clinical materials.
51:313-319.
2015
|
|
| 2015
|
Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling
2015
|
|
| 2015
|
Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow.
Molecular Cancer Research.
13:197-207.
2015
|
|
| 2015
|
Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors..
BoneKEy Reports.
4:689.
2015
|
|
| 2015
|
The Role of Osteoclasts in Early Dissemination of Prostate Cancer Tumor Cells..
Journal of cancer stem cell research.
3.
2015
|
|
| 2015
|
The bone marrow endosteal niche: how far from the surface?.
Journal of Cellular Biochemistry.
116:6-11.
2015
|
|
| 2014
|
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.
Stem Cells.
32:2845-2857.
2014
|
|
| 2014
|
HSCs and niche relations marked by CD166.
Blood.
124:471-472.
2014
|
|
| 2014
|
Molecular pathways: Niches in metastatic dormancy.
Clinical Cancer Research.
20:3384-3389.
2014
|
|
| 2014
|
Dentists' leadership-related educational experiences, attitudes, and past and current behavior.
Journal of Dental Education.
78:876-885.
2014
|
|
| 2014
|
Expanding the scholarship on leadership training in dental education.
Journal of Dental Education.
78:811-812.
2014
|
|
| 2014
|
Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo.
Stem Cells and Development.
23:689-701.
2014
|
|
| 2014
|
Human bone marrow mesenchymal progenitors: Perspectives on an optimized in vitro manipulation.
Frontiers in Cell and Developmental Biology.
2.
2014
|
|
| 2014
|
A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD
2014
|
|
| 2014
|
Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiation.
Bone.
66:111-120.
2014
|
|
| 2014
|
Niche inheritance: A cooperative pathway to enhance cancer cell fitness though ecosystem engineering.
Journal of Cellular Biochemistry.
115:1478-1485.
2014
|
|
| 2014
|
TAM macrophages promote growth and metastasis within the cancer ecosystem.
OncoImmunology.
3.
2014
|
|
| 2013
|
Developing the next generation of leaders in oral health.
Journal of Dental Education.
77:1508-1514.
2013
|
|
| 2013
|
Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.
Journal of Cellular Biochemistry.
114:2471-2478.
2013
|
|
| 2013
|
The cancer diaspora: Metastasis beyond the seed and soil hypothesis.
Clinical Cancer Research.
19:5849-5855.
2013
|
|
| 2013
|
The effect of low and high plasma levels of insulin-like growth factor-1 (IGF-1) on the morphology of major organs: Studies of laron dwarf and bovine growth hormone transgenic (bGHTg) mice
2013
|
|
| 2013
|
TBK1 regulates prostate cancer dormancy through mTOR inhibition.
Neoplasia.
15:1064-1074.
2013
|
|
| 2013
|
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.
Nature Communications.
4.
2013
|
|
| 2013
|
Cancer stem cells and their role in metastasis.
Pharmacology and Therapeutics.
138:285-293.
2013
|
|
| 2013
|
GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation.
PLoS One.
8.
2013
|
|
| 2013
|
Human very small embryonic-like cells generate skeletal structures, in vivo.
Stem Cells and Development.
22:622-630.
2013
|
|
| 2013
|
Impact of proteoglycan-4 and parathyroid hormone on articular cartilage.
Journal of Orthopaedic Research.
31:183-190.
2013
|
|
| 2013
|
An HLA-DRB1-coded signal transduction ligand facilitates inflammatory arthritis: A new mechanism of autoimmunity.
Journal of Immunology.
190:48-57.
2013
|
|
| 2013
|
Dentists' leadership-related perceptions, values, experiences and behavior results of a national survey.
Journal of the American Dental Association.
144:1397-1405.
2013
|
|
| 2013
|
Detection and isolation of human disseminated tumor cells in the murine bone marrow stem cell niche.
Methods in Molecular Biology.
1035:207-215.
2013
|
|
| 2013
|
The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
Journal of Cellular Biochemistry.
114:67-78.
2013
|
|
| 2012
|
Molecular signature and in vivo behavior of bone marrow endosteal and subendosteal stromal cell populations and their relevance to hematopoiesis.
Experimental Cell Research.
318:2427-2437.
2012
|
|
| 2012
|
Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cranial bone
2012
|
|
| 2012
|
Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.
Experimental Hematology.
40:685-694.
2012
|
|
| 2012
|
Prostate cancer and parasitism of the bone hematopoietic stem cell niche.
Critical Reviews in Eukaryotic Gene Expression.
22:131-148.
2012
|
|
| 2012
|
Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
Molecular Cancer Research.
10:703-712.
2012
|
|
| 2012
|
Where is leadership training being taught in U.S. dental schools?.
Journal of Dental Education.
76:713-720.
2012
|
|
| 2012
|
The prostate cancer bone marrow niche: More than just fertile soil.
Asian Journal of Andrology.
14:423-427.
2012
|
|
| 2012
|
Cancer Stem Cells and the Bone Marrow Microenvironment..
BoneKEy Reports.
2012.
2012
|
|
| 2012
|
Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype.
Molecular Cancer Research.
10:282-292.
2012
|
|
| 2012
|
Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment.
Blood.
119:1888-1896.
2012
|
|
| 2012
|
Effects of erythropoietin on the bone microenvironment.
Growth Factors.
30:22-28.
2012
|
|
| 2012
|
Leadership training for oral health professionals: A call to action.
Journal of Dental Education.
76:185-191.
2012
|
|
| 2012
|
Program design considerations for leadership training for dental and dental hygiene students.
Journal of Dental Education.
76:192-199.
2012
|
|
| 2012
|
Erythropoietin mediated bone formation is regulated by mTOR signaling.
Journal of Cellular Biochemistry.
113:220-228.
2012
|
|
| 2012
|
Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.
Neoplasia.
14:429-439.
2012
|
|
| 2012
|
Structure and function of the solid tumor niche
2012
|
|
| 2011
|
An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH
2011
|
|
| 2011
|
Homing of cancer cells to the bone.
Cancer Microenvironment.
4:221-235.
2011
|
|
| 2011
|
Mechanisms of cancer cell metastasis to the bone: A multistep process.
Future Oncology.
7:1285-1297.
2011
|
|
| 2011
|
Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.
American Journal of Pathology.
179:2431-2442.
2011
|
|
| 2011
|
Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.
Clinical Cancer Research.
17:5553-5558.
2011
|
|
| 2011
|
Erratum: CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression (Cancer and Metastasis Reviews (2010) 29 (709-722) DOI: 10.1007/s10555-010-9256- x).
Cancer and Metastasis Reviews.
30:269-270.
2011
|
|
| 2011
|
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.
Journal of Clinical Investigation.
121:1298-1312.
2011
|
|
| 2011
|
Perceptions of business skill development by graduates of the University of Michigan Dental School.
Journal of Dental Education.
75:505-517.
2011
|
|
| 2011
|
Mentoring of dental and dental hygiene faculty: A case study.
Journal of Dental Education.
75:291-299.
2011
|
|
| 2011
|
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.
Cancer Research.
71:614-624.
2011
|
|
| 2011
|
Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche.
Experimental Hematology.
39.
2011
|
|
| 2010
|
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
Cancer and Metastasis Reviews.
29:709-722.
2010
|
|
| 2010
|
Prospective identification and skeletal localization of cells capable of multilineage differentiation in vivo.
Stem Cells and Development.
19:1557-1570.
2010
|
|
| 2010
|
Erythropoietin couples hematopoiesis with bone formation.
PLoS One.
5.
2010
|
|
| 2010
|
Dysfunctional niches as a root of hematopoietic malignancy.
Cell Stem Cell.
6:399-400.
2010
|
|
| 2010
|
An in vivo model to study and manipulate the hematopoietic stem cell niche.
Blood.
115:2592-2600.
2010
|
|
| 2010
|
GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche.
Experimental Hematology.
38:132-140.
2010
|
|
| 2010
|
Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.
International Journal of Cancer.
126:1513-1520.
2010
|
|
| 2010
|
Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.
Cancer Research.
70:471-480.
2010
|
|
| 2010
|
Adaptation of airline crew resource management principles to dentistry.
Journal of the American Dental Association.
141:1010-1018.
2010
|
|
| 2010
|
GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
Neoplasia.
12:116-127.
2010
|
|
| 2010
|
Probing the CXCR6/CXCL16 Axis: Targeting Prevention of Prostate Cancer Metastasis
2010
|
|
| 2009
|
Creation of a Scholars Program in Dental Leadership (SPDL) for dental and dental hygiene students.
Journal of Dental Education.
73:1139-1143.
2009
|
|
| 2009
|
Expression of PGK1 by prostate cancer cells induces bone formation.
Molecular Cancer Research.
7:1595-1604.
2009
|
|
| 2009
|
Hedgehog Signaling Is Dispensable for Adult Hematopoietic Stem Cell Function.
Cell Stem Cell.
4:548-558.
2009
|
|
| 2009
|
Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids.
Clinical materials.
30:3020-3027.
2009
|
|
| 2009
|
Ability of dental students to deliver oxygen in a medical emergency.
Journal of Dental Education.
73:499-508.
2009
|
|
| 2009
|
Innovative mouse models for metastatic disease.
Drug Discovery Today: Disease Models.
6:27-31.
2009
|
|
| 2008
|
CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.
Cancer Research.
68:10367-10376.
2008
|
|
| 2008
|
CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
Clinical and Experimental Metastasis.
25:765-776.
2008
|
|
| 2008
|
Advancing treatment for metastatic bone cancer: Consensus recommendations from the second cambridge conference.
Clinical Cancer Research.
14:6387-6395.
2008
|
|
| 2008
|
Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.
Journal of Cellular Biochemistry.
105:370-380.
2008
|
|
| 2008
|
Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche.
Stem Cells.
26:2042-2051.
2008
|
|
| 2008
|
Stromal-derived factor-lα (CXCL 12) leveis increase in periodontal disease.
Journal of Periodontology.
79:845-853.
2008
|
|
| 2008
|
CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Molecular Cancer Research.
6:546-554.
2008
|
|
| 2008
|
The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.
Journal of Biological Chemistry.
283:4283-4294.
2008
|
|
| 2008
|
An in vivo mouse model for human prostate cancer metastasis.
Neoplasia.
10:371-379.
2008
|
|
| 2008
|
The bone marrow niche: Habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.
Leukemia.
22:941-950.
2008
|
|
| 2007
|
New trends in the treatment of bone metastasis.
Journal of Cellular Biochemistry.
102:1095-1102.
2007
|
|
| 2007
|
The evolving biology and treatment of prostate cancer.
Journal of Clinical Investigation.
117:2351-2361.
2007
|
|
| 2007
|
Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation.
Blood.
110:82-90.
2007
|
|
| 2007
|
Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells.
Blood.
109:3706-3712.
2007
|
|
| 2007
|
Lead exposure and periodontitis in US adults.
Journal of Periodontal Research.
42:45-52.
2007
|
|
| 2007
|
A glycolytic mechanism regulating an angiogenic switch in prostate cancer.
Cancer Research.
67:149-159.
2007
|
|
| 2007
|
Expression and activation of αvβ3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells
2007
|
|
| 2006
|
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Cancer and Metastasis Reviews.
25:573-587.
2006
|
|
| 2006
|
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis.
BMC Cancer.
6.
2006
|
|
| 2006
|
Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells.
Stem Cells.
24:1573-1582.
2006
|
|
| 2006
|
Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.
Bone.
38:497-508.
2006
|
|
| 2005
|
Cell-to-cell contact is critical for the survival of hematopoietic progenitor cells on osteoblasts.
Cytokine.
32:155-162.
2005
|
|
| 2005
|
Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone
2005
|
|
| 2005
|
The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
Cancer Research.
65:8818-8825.
2005
|
|
| 2005
|
Clusterin inhibits apoptosis by interacting with activated Bax.
Nature Cell Biology.
7:909-915.
2005
|
|
| 2005
|
Blood and bone: Two tissues whose fates are intertwined to create the hematopoietic stem-cell niche.
Blood.
105:2631-2639.
2005
|
|
| 2005
|
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Journal of Bone and Mineral Research.
20:318-329.
2005
|
|
| 2005
|
Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis.
Cellular Signalling.
17:1578-1592.
2005
|
|
| 2005
|
Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression.
Urologic Oncology: seminars and original investigations.
23:261-267.
2005
|
|
| 2005
|
The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis.
Brazilian Journal of Medical and Biological Research.
38:1449-1454.
2005
|
|
| 2004
|
Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.
Cancer Research.
64:4302-4308.
2004
|
|
| 2004
|
N-linked sialyated sugar receptors support haematopoietic cell-osteoblast adhesions.
British Journal of Haematology.
124:534-546.
2004
|
|
| 2004
|
Vascular Endothelial Growth Factor Contributes to the Prostate Cancer-Induced Osteoblast Differentiation Mediated by Bone Morphogenetic Protein.
Cancer Research.
64:994-999.
2004
|
|
| 2004
|
Cancer cells homing to bone: the significance of chemotaxis and cell adhesion..
Cancer Treatment and Research.
118:291-309.
2004
|
|
| 2004
|
Detection and isolation of circulating tumor cells in urologic cancers: A review.
Neoplasia.
6:302-309.
2004
|
|
| 2003
|
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Journal of Cellular Biochemistry.
89:462-473.
2003
|
|
| 2002
|
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4..
Nature Immunology.
3:687-694.
2002
|
|
| 2002
|
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Cancer Research.
62:1832-1837.
2002
|
|
| 2001
|
Hepatocyte growth factor is secreted by osteoblasts and cooperatively permits the survival of haematopoietic progenitors.
British Journal of Haematology.
112:438-448.
2001
|
|
| 2001
|
Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone.
Cancer and Metastasis Reviews.
20:333-349.
2001
|
|
| 2000
|
Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3,-E1 cells.
Journal of Cellular Biochemistry.
78:607-616.
2000
|
|
| 2000
|
Bone marrow accessory cells regulate human bone precursor cell development.
Experimental Hematology.
28:815-825.
2000
|
|
| 2000
|
Human osteoblast-like cells and osteosarcoma cell lines synthesize macrophage inhibitory protein 1α in response to interleukin 1β and tumour necrosis factor α stimulation in vitro.
British Journal of Haematology.
108:275-283.
2000
|
|
| 2000
|
Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.
Journal of Clinical Investigation.
106:1331-1339.
2000
|
|
| 2000
|
The Hematopoietic Microenvironment: Osteoblasts and The Hematopoietic Microenvironment..
Hematology.
4:421-426.
2000
|
|
| 1999
|
Osteoblasts and The Hematopoietic Microenvironment..
Hematology.
4:421-426.
1999
|
|
| 1998
|
Protein Extracts of Dentin Affect Proliferation and Differentiation of Osteoprogenitor Cells in Vitro.
Journal of Periodontology.
69:1247-1255.
1998
|
|
| 1998
|
The role of osteoblasts in the hematopoietic microenvironment.
Stem Cells.
16:7-15.
1998
|
|
| 1998
|
Ultrastructural aspects of cytomegalovirus-infected fibroblastic stromal cells of human bone marrow.
Tissue and Cell.
30:398-406.
1998
|
|
| 1997
|
Human osteosarcomas inhibit hematopoietic colony formation: Partial reversal by antibody to transforming growth factor-β1.
Bone.
21:353-361.
1997
|
|
| 1997
|
Infection and replication of human cytomegalovirus in bone marrow stromal cells: Effects on the production of IL-6, MIP-1α, and TGF-β1.
Bone Marrow Transplantation.
19:471-480.
1997
|
|
| 1997
|
Augmented production of interleukin-6 by normal human osteoblasts in response to CD34+ hematopoietic bone marrow cells in vitro.
Blood.
89:1165-1172.
1997
|
|
| 1996
|
Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: Identification and partial characterization of cell-associated isoforms.
Experimental Hematology.
24:509-517.
1996
|
|
| 1996
|
Human osteoblasts support human hematopoietic progenitor cells in in vitro bone marrow cultures.
Blood.
87:518-524.
1996
|
|
| 1996
|
Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.
British Journal of Haematology.
93:273-279.
1996
|
|
| 1994
|
Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell..
Journal of Experimental Medicine.
180:1115-1127.
1994
|
|
| 1994
|
Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor.
Journal of Experimental Medicine.
179:1677-1682.
1994
|
|
| 1994
|
Bcl-2 Inhibits T-Cell-mediated Cytolysis of a Leukemia Cell Line.
Cancer Research.
54:4851-4854.
1994
|
|
| 1993
|
A strategy for constructing inducible expression plasmids for T-lymphocytes.
1993
|
|
| 1993
|
Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3'-kinase in interleukin-2-dependent T-cells.
Journal of Biological Chemistry.
268:20031-20036.
1993
|
|
| 1993
|
Protooncogene-encoded protein kinases in interleukin-2 signal transduction.
Seminars in Immunology.
5:327-336.
1993
|
|
| 1992
|
Effects of interleukin-1 β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro.
Inflammation.
16:587-601.
1992
|
|
| 1992
|
Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: Implications for mechanisms of IL-2-signal transduction.
Cytokine.
4:441-453.
1992
|
|
